Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Holdings
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Appointed director

Allergan plc (AGN) Create: Alert

All | News | Filings
Date FiledTypeDescription
05/21/2020 15-12B Form 15-12B - Securities registration termination [Section 12(b)]:
05/19/2020 EFFECT Form EFFECT - Notice of Effectiveness:
05/19/2020 EFFECT Form EFFECT - Notice of Effectiveness:
05/19/2020 EFFECT Form EFFECT - Notice of Effectiveness:
05/19/2020 EFFECT Form EFFECT - Notice of Effectiveness:
05/14/2020 POS AM Form POS AM - Post-Effective amendments for registration statement:
05/14/2020 POS AM Form POS AM - Post-Effective amendments for registration statement:
05/14/2020 POS AM Form POS AM - Post-Effective amendments for registration statement:
05/14/2020 POSASR Form POSASR - Post-effective Amendment to an automatic shelf registration statement:
05/14/2020 POS AM Form POS AM - Post-Effective amendments for registration statement:
05/14/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
05/14/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
05/14/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
05/14/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
05/14/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
05/14/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
05/14/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
05/14/2020 8-K Quarterly results
05/12/2020 4 Basgoz Nesli (Director) has filed a Form 4 on Allergan plc
Txns: Disposed/sold 6,889 shares @ $0
Disposed/sold 2,790 options @ $90.22, valued at $251.7k
Disposed/sold 3,691 options @ $73.14, valued at $270k
Disposed/sold 2,619 options @ $70.79, valued at $185.4k
05/12/2020 4 Boccuzi Joseph H (Director) has filed a Form 4 on Allergan plc
Txns: Disposed/sold 3,605 shares @ $0
05/11/2020 4 HUGIN ROBERT J (Director) has filed a Form 4 on Allergan plc
Txns: Disposed/sold 4,294 shares @ $0
05/11/2020 4 BODINE CHRIS W (Director) has filed a Form 4 on Allergan plc
Txns: Disposed/sold 18,615 shares @ $0
05/11/2020 4 DArecca James (SVP Chief Accounting Officer) has filed a Form 4 on Allergan plc
Txns: Disposed/sold 3,511 shares @ $0
Disposed/sold 6,324 restricted stock units @ $0
Disposed/sold 1,169 options @ $296.14, valued at $346.2k
Disposed/sold 4,957 options @ $224, valued at $1.1M
Disposed/sold 3,534 rights @ $0
05/11/2020 4 Brown Adriane M (Director) has filed a Form 4 on Allergan plc
Txns: Disposed/sold 2,916 shares @ $0
05/11/2020 4 Bailey A Robert D (EVP Chief Legal Off & Corp Sec) has filed a Form 4 on Allergan plc
Txns: Disposed/sold 17,629 shares @ $0
Disposed/sold 16,800 restricted stock units @ $0
Disposed/sold 16,524 options @ $224, valued at $3.7M
Disposed/sold 3,852 options @ $103.79, valued at $399.8k
Disposed/sold 509 options @ $196.16, valued at $99.8k
Disposed/sold 9,750 options @ $103.79, valued at $1M
Disposed/sold 12,304 options @ $196.16, valued at $2.4M
Disposed/sold 17,670 rights @ $0
05/11/2020 4 FREYMAN THOMAS C (Director) has filed a Form 4 on Allergan plc
Txns: Disposed/sold 2,983 shares @ $0
05/11/2020 4 WALSH MATTHEW M (EVP, CFO) has filed a Form 4 on Allergan plc
Txns: Disposed/sold 12,039 shares @ $0
Disposed/sold 27,618 restricted stock units @ $0
Disposed/sold 28,021 rights @ $0
05/11/2020 4 DAVIDSON CAROL ANTHONY (Director) has filed a Form 4 on Allergan plc
Txns: Disposed/sold 2,105 shares @ $0
05/11/2020 4 Swanton Wayne R (EVP, Global Operations) has filed a Form 4 on Allergan plc
Txns: Disposed/sold 8,915 shares @ $0
Disposed/sold 12,050 restricted stock units @ $0
Disposed/sold 5,508 options @ $224, valued at $1.2M
Disposed/sold 1,369 options @ $307.51, valued at $421k
Disposed/sold 12,129 rights @ $0
05/11/2020 4 Nicholson C. David (EVP Chief R&D Officer) has filed a Form 4 on Allergan plc
Txns: Disposed/sold 9,999 shares @ $0
Disposed/sold 25,201 restricted stock units @ $0
Disposed/sold 17,006 options @ $215.77, valued at $3.7M
Disposed/sold 26,506 rights @ $0
05/11/2020 4 Greenberg Michael Eldon (Director) has filed a Form 4 on Allergan plc
Txns: Disposed/sold 1,693 shares @ $0
05/11/2020 4 Meury William (EVP & Chief Commercial Officer) has filed a Form 4 on Allergan plc
Txns: Disposed/sold 7,434 shares @ $0
Disposed/sold 25,201 restricted stock units @ $0
Disposed/sold 19,278 options @ $224, valued at $4.3M
Disposed/sold 1 options @ $63.51, valued at $63.5
Disposed/sold 1,387 options @ $72.07, valued at $100k
Disposed/sold 1,246 options @ $80.2, valued at $99.9k
Disposed/sold 509 options @ $196.16, valued at $99.8k
Disposed/sold 16,081 options @ $63.51, valued at $1M
Disposed/sold 10,089 options @ $72.07, valued at $727.1k
Disposed/sold 21,621 options @ $80.2, valued at $1.7M
Disposed/sold 12,304 options @ $196.16, valued at $2.4M
05/11/2020 4 McDonnell Peter J (Director) has filed a Form 4 on Allergan plc
Txns: Disposed/sold 6,352 shares @ $0
05/11/2020 4 SAUNDERS BRENT L (Chairman, President and CEO) has filed a Form 4 on Allergan plc
Txns: Disposed/sold 149,384 shares @ $0
Disposed/sold 79,805 restricted stock units @ $0
Disposed/sold 104,651 options @ $224, valued at $23.4M
Disposed/sold 3,291 options @ $91.13, valued at $299.9k
Disposed/sold 1,018 options @ $196.16, valued at $199.7k
Disposed/sold 9,446 options @ $70.79, valued at $668.7k
Disposed/sold 3,691 options @ $73.14, valued at $270k
Disposed/sold 2,790 options @ $90.22, valued at $251.7k
Disposed/sold 219,667 options @ $91.13, valued at $20M
Disposed/sold 62,547 options @ $196.16, valued at $12.3M
Disposed/sold 1 options @ $196.16, valued at $196.2
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy